Vit D concentration associated with reduced risk of cancer

March 14, 2018

(HealthDay)—Higher plasma concentration of 25-hydroxyvitamin D is associated with reduced risk of total cancer in a Japanese population, according to a study published online March 7 in The BMJ.

Sanjeev Budhathoki, M.D., from the National Cancer Center in Tokyo, and colleagues examined the between pre-diagnostic circulating vitamin D concentration and the risk of . They performed a nested case-cohort study in which a total of 3,301 incident cases of cancer and 4,044 randomly selected subcohort participants within the Japan Public Health Center-based Prospective Study cohort were included.

The researchers found that there was an inverse correlation for 25-hydroxyvitamin D with the risk of total cancer, with multivariable adjusted hazard ratios of 0.81 (95 percent confidence interval [CI], 0.7 to 0.94), 0.75 (95 percent CI, 0.65 to 0.87), and 0.78 (95 percent CI, 0.67 to 0.91) for the second to fourth quarters versus the lowest quarter, respectively (P for trend = 0.001). There was also an inverse correlation for liver cancer, with corresponding hazard ratios of 0.7 (95 percent CI, 0.44 to 1.13), 0.65 (95 percent CI, 0.40 to 1.06), and 0.45 (95 percent CI, 0.26 to 0.79) (P for trend = 0.006). The overall hazard ratios were not substantially altered by removing cases of cancer at one specific site from total cancer cases.

"These findings support the hypothesis that vitamin D has protective effects against cancers at many sites," the authors write.

Fujirebio Inc. played a role in measurement of plasma 25-hydroxyvitamin D.

Explore further: Total, saturated fat linked to increased risk of lung cancer

More information: Abstract/Full Text

Related Stories

Total, saturated fat linked to increased risk of lung cancer

July 28, 2017
(HealthDay)—High intake of total and saturated fat is associated with increased risk of lung cancer, according to research published online July 25 in the Journal of Clinical Oncology.

25(OH)D levels linked to survival in pancreatic cancer

June 23, 2016
(HealthDay)—Prediagnostic 25-hydroxyvitamin D (25[OH]D) levels are associated with survival in pancreatic cancer, according to a study published online June 20 in the Journal of Clinical Oncology.

Soy food, isoflavone intake not linked to endometrial cancer

February 7, 2015
(HealthDay)—Soy food/isoflavone intake is not associated with endometrial cancer risk in Japanese women, according to a study published in the February issue of BJOG: An International Journal of Obstetrics & Gynaecology.

PPI-gastric cancer link remains after H. pylori eradication

November 2, 2017
(HealthDay)—Long-term proton pump inhibitor (PPI) use is associated with increased risk of gastric cancer (GC) even after Helicobacter pylori (HP) eradication therapy, according to a study published online Oct. 31 in Gut.

Stem cell factor tied to reduced risk of cardiac events, death

September 1, 2017
(HealthDay)—High levels of stem cell factor (SCF) are associated with reduced risk of mortality and cardiovascular events, according to a study published online Aug. 26 in the Journal of Internal Medicine.

Low vitamin D levels tied to increased cancer risk in IBD

May 6, 2014
(HealthDay)—Low plasma levels of 25-hydroxyvitamin D (25[OH]D) are associated with an increased risk of cancer in patients with inflammatory bowel diseases (IBD), according to a study published in the May issue of Clinical ...

Recommended for you

Treatment shown to improve the odds against bone marrow cancer

December 15, 2018
Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Lethal combination: Drug cocktail turns off the juice to cancer cells

December 12, 2018
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth—this was discovered by researchers from the University of Basel's Biozentrum two years ago. In a follow-up study, ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.